Middle East Healthcare Company
4009.SRSAUHealthcare● Active
$33.00
+$0.60(+1.85%)
Market Cap$3.0B
P/E Ratio—
52W High$60.7
52W Low$28.66
Middle East Healthcare Company (4009.SR) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 4009.SR · as of 2026-06-15
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.30B | $0.31B | $0.18B | $0.08B | $0.02B |
| Depreciation & Amort. | $0.25B | $0.22B | $0.19B | $0.15B | $0.14B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | ($0.15B) | $0.11B | ($0.41B) | ($0.23B) | ($0.12B) |
| Net Cash from Operations | $0.36B | $0.77B | $0.19B | $0.08B | $0.08B |
| Investing Activities | |||||
| Capital Expenditure | ($0.46B) | ($0.48B) | ($0.23B) | ($0.25B) | ($0.42B) |
| Purchases of Investments | ($0.01B) | ($0.05B) | ($0.01B) | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.34B) | ($0.51B) | ($0.24B) | ($0.25B) | ($0.42B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($0.05B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.04B | ($0.04B) | $0.25B | $0.24B | $0.41B |
| Net Cash from Financing | ($0.04B) | ($0.26B) | $0.08B | $0.16B | $0.35B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.10B) | $0.29B | ($0.04B) | ($0.17B) | ($0.34B) |
| FCF Margin %(computed) | -3.22% | 9.94% | -1.56% | -8.06% | -18.20% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · B
Explore more Middle East Healthcare Company data
About Middle East Healthcare Company (4009.SR) Cash Flow Statement
Middle East Healthcare Company generated operating cash flow of $0.36B and free cash flow of ($0.10B) for 2025 — a FCF margin of -3.22%. Capital expenditure was ($0.46B).
Frequently asked questions
4009.SR · 4 questionsMiddle East Healthcare Company generated free cash flow of ($0.10B) for 2025, down 134.8% year-over-year.
4009.SR free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15